Company news from the 07/18/06 News Brief

Share this article:
Santarus, a specialty pharmaceutical company focused on products treating gastrointestinal diseases, has launched a new full-service Web site to coincide with the launch of its new capsule formulation Zegerid, an immediate release oral proton pump inhibitor for nighttime acid control. The site, zegerid.com, was designed and developed by Compass Healthcare Communications.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.